Assessing the Upcoming Dividend and Financial Health of Goodman Group (GMGSF) Goodman Group (GMGSF) recently announced a dividend of $0.15 per share, payable on 2024-02-23, with the ex-dividend date set for 2023-12-28. As investors look forward to this upcoming payment, the spotlight also shines …
Understanding the Upcoming Dividend Payout and Historical Performance Transurban Group(TRAUF) recently announced a dividend of $0.3 per share, payable on 2024-02-13, with the ex-dividend date set for 2023-12-28. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend …
Delving Into the Dividends of TC Energy Corp (NYSE:TRP) TC Energy Corp (NYSE:TRP) recently announced a dividend of $0.93 per share, payable on 2024-01-31, with the ex-dividend date set for 2023-12-28. As investors look forward to this upcoming payment, the spotlight also shines on …
A silicon wafer with chips etched into at a research facility, in Sunnyvale, California, US. (POOL New / reuters) Semiconductors and chips proved to be a hot talking point in 2023 for business, with the rise of artificial intelligence (AI) and what seemed to …
Grainger plc (LON:GRI) has announced that it will be increasing its dividend from last year's comparable payment on the 14th of February to £0.0437. Even though the dividend went up, the yield is still quite low at only 2.4%. See our latest analysis for …
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. But the reality is that …
Key Insights Using the 2 Stage Free Cash Flow to Equity, Bapcor fair value estimate is AU$9.82 Current share price of AU$5.55 suggests Bapcor is potentially 43% undervalued The AU$6.96 analyst price target for BAP is 29% less than our estimate of fair value …
Key Insights The projected fair value for Neuren Pharmaceuticals is AU$43.02 based on 2 Stage Free Cash Flow to Equity Current share price of AU$24.04 suggests Neuren Pharmaceuticals is potentially 44% undervalued Analyst price target for NEU is AU$26.43 which is 39% below our …
Key Insights The projected fair value for Iluka Resources is AU$9.11 based on 2 Stage Free Cash Flow to Equity Iluka Resources is estimated to be 27% undervalued based on current share price of AU$6.68 Analyst price target for ILU is AU$8.28 which is …
While it may not be enough for some shareholders, we think it is good to see the Cogeco Inc. (TSE:CGO) share price up 20% in a single quarter. But that doesn't help the fact that the three year return is less impressive. Truth be …